Trials / Completed
CompletedNCT01190202
Epidemiology Study of Malaria Transmission Intensity in Africa
Epidemiology Study of Malaria Transmission Intensity in Sub-Saharan Africa
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 21,618 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 6 Months
- Healthy volunteers
- Accepted
Summary
The aim of this epidemiology study is to characterize in a standardized way malaria transmission intensity at the clinical trial centers participating in study 110021 (NCT00866619).
Detailed description
This study is a multicenter epidemiology study at centers that are participating in GSK's pivotal Phase III candidate malaria vaccine 110021 ( NCT00866619) trial and will involve 4 annual cross sectional surveys performed preferably at peak transmission. There will be no study vaccine administered in this epidemiology study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Blood sampling | Capillary blood samples collected by finger/heel prick |
| PROCEDURE | Assessment of body temperature | Assessment of axial body temperature with a digital thermometer |
Timeline
- Start date
- 2011-03-14
- Primary completion
- 2013-12-20
- Completion
- 2013-12-20
- First posted
- 2010-08-27
- Last updated
- 2020-08-18
- Results posted
- 2020-08-18
Locations
8 sites across 6 countries: Burkina Faso, Gabon, Ghana, Kenya, Malawi, Tanzania
Source: ClinicalTrials.gov record NCT01190202. Inclusion in this directory is not an endorsement.